Evidence map›Paper›PMID 29662689›Full record

ArticleBMJ global health2018

Supporting the development of a health benefits package in Malawi.

Jessica Ochalek, Paul Revill, Gerald Manthalu, Finn McGuire, Dominic Nkhoma, Alexandra Rollinger, Mark Sculpher, Karl Claxton

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Jessica OchalekCentre for Health Economics, University of York, York, UK.ORCID 0000-0003-0744-1178
Paul RevillCentre for Health Economics, University of York, York, UK.
Gerald ManthaluDepartment of Planning and Policy Development, Ministry of Health, Lilongwe, Malawi.
Finn McGuireDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Dominic NkhomaMinistry of Agriculture, Irrigation and Water Development, Lilongwe, Malawi.
Alexandra RollingerCentre for Health Economics, University of York, York, UK.
Mark SculpherCentre for Health Economics, University of York, York, UK.
Karl ClaxtonCentre for Health Economics, University of York, York, UK.
University of York · GBLondon School of Hygiene & Tropical Medicine · GBMinistry of Health · MWMinistry of Water Resources and Irrigation · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malawi, like many low-income and middle-income countries, has used health benefits packages (HBPs) to allocate scarce resources to key healthcare interventions. With no widely accepted method for their development, HBPs often promise more than can be delivered, given available resources. An analytical framework is developed to guide the design of HBPs that can identify the potential value of including and implementing different interventions. It provides a basis for informing meaningful discussions between governments, donors and other stakeholders around the trade-offs implicit in package design. Metrics of value, founded on an understanding of the health opportunity costs of the choices faced, are used to quantify the scale of the potential net health impact (net disability adjusted life years averted) or the amount of additional healthcare resources that would be required to deliver similar net health impacts with existing interventions (the financial value to the healthcare system). The framework can be applied to answer key questions around, for example: the appropriate scale of the HBP; which interventions represent 'best buys' and should be prioritised; where investments in scaling up interventions and health system strengthening should be made; whether the package should be expanded; costs of the conditionalities of donor funding and how objectives beyond improving population health can be considered. This is illustrated using data from Malawi. The framework was successfully applied to inform the HBP in Malawi, as a core component of the country's Health Sector Strategic Plan II 2017-2022.

Indexed as

health economicshealth policyhealth systems

Identifiers

PMID29662689
PMCPMC5898345
OpenAlexW2798150273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.